Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
FindAir is a med-tech company focused on digital respiratory care. It offers smart add-on sensors for inhalers, inhalation technique training devices, patient apps, remote monitoring platforms, and SDK/API access. Its core goal is to provide medication adherence, inhalation technique, and real-world medication-use data for asthma and COPD treatment. Its target customers are clearly more B2B/B2B2C, including healthcare providers, clinical research organizations, pharmaceutical companies, remote patient monitoring providers, and medical device distributors.
The product line centers on FindAir ONE Add-ons, which can be attached to existing pMDI/DPI inhalers to record the time, date, location, and environmental data for each use, while monitoring adherence, overuse, inhalation flow, technique quality, and inhaler angle. Smarthaler Trainer is designed for non-invasive inhalation training in both home and professional settings. On the software side, FindAir provides iOS/Android patient apps, a clinician data platform, research tools, data export, and SDK/API access for third-party systems. The site also mentions integrations with EHR, RPM, research systems, and proprietary apps.
The official website does not disclose plans, device unit prices, subscription fees, or bulk purchasing prices. Sales are mainly driven through booking meetings, contacting sales, or using “Order Device,” suggesting a project-based and channel-partnership model. On compliance, the site mentions GDPR data privacy, wireless compliance, a quality management system, medical-grade materials, CE certification, risk analysis, and validation processes. However, it does not specify data hosting regions, SLA, permission models, or self-hosting capabilities.
Its strengths are the closed loop formed by hardware, apps, platform, APIs, and clinical research scenarios. The add-on approach helps capture data quickly without changing existing inhalers, and supports scaling from small clinical pilots to commercial deployments. The weaknesses are limited publicly available commercial information, with some models still marked as Coming Soon. There are also inconsistencies in certain product specifications and model descriptions on the site, so buyers should verify details before procurement. Its medical device nature also means international deployment must take into account local registration, data compliance, and after-sales support capabilities.
FindAir is better suited for organizations with needs in chronic respiratory disease management, clinical trials, remote follow-up, or smart drug-delivery device integration, rather than ordinary individuals buying directly. The site provides no information on access or payment from China, so the status is unknown. For deployment in China, organizations should evaluate website/API connectivity, Bluetooth device certification, medical device registration, cross-border personal information transfer, and local cloud deployment requirements. Alternatives to consider include Propeller Health, Adherium Hailie, Teva Digihaler, as well as local Chinese vendors in chronic respiratory disease management and medical IoT.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on findair.eu official site.
findair.eu is an Poland Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach findair.eu directly.